ReP USP - Resultado da busca

Artigo de periodico
Aberrant phenotypes in acute myeloid leukemia and its relationship with prognosis and survival: a systematic review and meta-analysis (2020)
Pinheiro, Lucio Henrique Sousa; Trindade, Louise Dantas; Costa, Amanda Fernandes de Oliveira; Silva, Nathanielly de Lima; Sandes, Alex Freire; Nunes, Marco Antonio Prado; Correa, Cristiane Bani; Almeida, Carlos Arthur Cardoso; Cruz, Geydson Silveira da; Lyra Júnior, Divaldo Pereira de; Schimieguel, Dulce Marta
Source: International Journal of Hematology-Oncology and Stem Cell Research. Unidade: FMRP
Subjects: FENÓTIPOS, LEUCEMIA MIELOIDE AGUDA, IMUNOFENOTIPAGEM, PROGNÓSTICO, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, Lucio Henrique Sousa et al. Aberrant phenotypes in acute myeloid leukemia and its relationship with prognosis and survival: a systematic review and meta-analysis. International Journal of Hematology-Oncology and Stem Cell Research, v. 14, n. 4, p. 274-288, 2020Tradução . . Disponível em: https://doi.org/10.18502/ijhoscr.v14i4.4484. Acesso em: 06 nov. 2024.
APA
Pinheiro, L. H. S., Trindade, L. D., Costa, A. F. de O., Silva, N. de L., Sandes, A. F., Nunes, M. A. P., et al. (2020). Aberrant phenotypes in acute myeloid leukemia and its relationship with prognosis and survival: a systematic review and meta-analysis. International Journal of Hematology-Oncology and Stem Cell Research, 14( 4), 274-288. doi:10.18502/ijhoscr.v14i4.4484
NLM
Pinheiro LHS, Trindade LD, Costa AF de O, Silva N de L, Sandes AF, Nunes MAP, Correa CB, Almeida CAC, Cruz GS da, Lyra Júnior DP de, Schimieguel DM. Aberrant phenotypes in acute myeloid leukemia and its relationship with prognosis and survival: a systematic review and meta-analysis [Internet]. International Journal of Hematology-Oncology and Stem Cell Research. 2020 ; 14( 4): 274-288.[citado 2024 nov. 06 ] Available from: https://doi.org/10.18502/ijhoscr.v14i4.4484
Vancouver
Pinheiro LHS, Trindade LD, Costa AF de O, Silva N de L, Sandes AF, Nunes MAP, Correa CB, Almeida CAC, Cruz GS da, Lyra Júnior DP de, Schimieguel DM. Aberrant phenotypes in acute myeloid leukemia and its relationship with prognosis and survival: a systematic review and meta-analysis [Internet]. International Journal of Hematology-Oncology and Stem Cell Research. 2020 ; 14( 4): 274-288.[citado 2024 nov. 06 ] Available from: https://doi.org/10.18502/ijhoscr.v14i4.4484
Artigo de periodico
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy (2019)
Solomon, Scott R; Martin, Andrew St; Shah, Nirav N; Fatobene, Giancarlo; Malki, Monzr M. Al; Ballen, Karen K; Bashey, Asad; Bejanyan, Nelli; Meade, Javier Bolanos; Rocha, Vanderson
Source: Blood advances. Unidade: FM
Subjects: TRANSPLANTE HOMÓLOGO, LINFÓCITOS T, LEUCEMIA MIELOIDE AGUDA, DOENÇAS DA MEDULA ÓSSEA, DOENÇA ENXERTO-HOSPEDEIRO, FÁRMACOS IMUNOSSUPRESSORES, CONDICIONAMENTO, SOBREVIVÊNCIA LIVRE DE DOENÇA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOLOMON, Scott R et al. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood advances, v. 3, n. 19, p. 2836-2844, 2019Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2019000627. Acesso em: 06 nov. 2024.
APA
Solomon, S. R., Martin, A. S., Shah, N. N., Fatobene, G., Malki, M. M. A., Ballen, K. K., et al. (2019). Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood advances, 3( 19), 2836-2844. doi:10.1182/bloodadvances.2019000627
NLM
Solomon SR, Martin AS, Shah NN, Fatobene G, Malki MMA, Ballen KK, Bashey A, Bejanyan N, Meade JB, Rocha V. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy [Internet]. Blood advances. 2019 ; 3( 19): 2836-2844.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1182/bloodadvances.2019000627
Vancouver
Solomon SR, Martin AS, Shah NN, Fatobene G, Malki MMA, Ballen KK, Bashey A, Bejanyan N, Meade JB, Rocha V. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy [Internet]. Blood advances. 2019 ; 3( 19): 2836-2844.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1182/bloodadvances.2019000627
Artigo de periodico
Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia (2019)
Yoshinari Junior, Gerson Hiroshi; Fassoni, Artur Cesar; Mello, Luis Fernando; Rego, Eduardo Magalhaes
Source: Plos one. Unidades: FM, FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, SOBREVIVÊNCIA LIVRE DE DOENÇA, MODELOS MATEMÁTICOS, TERAPIA BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOSHINARI JUNIOR, Gerson Hiroshi et al. Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia. Plos one, v. 14, n. 8, 2019Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0221011. Acesso em: 06 nov. 2024.
APA
Yoshinari Junior, G. H., Fassoni, A. C., Mello, L. F., & Rego, E. M. (2019). Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia. Plos one, 14( 8). doi:10.1371/journal.pone.0221011
NLM
Yoshinari Junior GH, Fassoni AC, Mello LF, Rego EM. Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia [Internet]. Plos one. 2019 ; 14( 8):[citado 2024 nov. 06 ] Available from: https://doi.org/10.1371/journal.pone.0221011
Vancouver
Yoshinari Junior GH, Fassoni AC, Mello LF, Rego EM. Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia [Internet]. Plos one. 2019 ; 14( 8):[citado 2024 nov. 06 ] Available from: https://doi.org/10.1371/journal.pone.0221011
Artigo de periodico
Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience (2017)
Benicio, Mariana Tereza de Lira; Ribeiro, Ana Flávia Tibúrcio; Américo, Andre D.; Furtado, Felipe M.; Glória, Ana B.; Lima, Aleide S.; Santos, Silvana M.; Xavier, Sandra G.; Lucena-Araujo, Antonio R.; Fagundes, Evandro M.; Rego, Eduardo Magalhães
Source: Leukemia Research. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, SOBREVIVÊNCIA LIVRE DE DOENÇA, PROGNÓSTICO, TAXA DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENICIO, Mariana Tereza de Lira et al. Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience. Leukemia Research, v. 60, p. 109-114, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2017.07.005. Acesso em: 06 nov. 2024.
APA
Benicio, M. T. de L., Ribeiro, A. F. T., Américo, A. D., Furtado, F. M., Glória, A. B., Lima, A. S., et al. (2017). Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience. Leukemia Research, 60, 109-114. doi:10.1016/j.leukres.2017.07.005
NLM
Benicio MT de L, Ribeiro AFT, Américo AD, Furtado FM, Glória AB, Lima AS, Santos SM, Xavier SG, Lucena-Araujo AR, Fagundes EM, Rego EM. Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience [Internet]. Leukemia Research. 2017 ; 60 109-114.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.leukres.2017.07.005
Vancouver
Benicio MT de L, Ribeiro AFT, Américo AD, Furtado FM, Glória AB, Lima AS, Santos SM, Xavier SG, Lucena-Araujo AR, Fagundes EM, Rego EM. Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience [Internet]. Leukemia Research. 2017 ; 60 109-114.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.leukres.2017.07.005
Artigo de periodico
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL (2013)
Rego, Eduardo Magalhaes; Kim, Haesook T.; Ruiz-Argüelles, Guillermo J.; Undurraga, Maria Soledad; Uriarte, Maria del Rosario; Jacomo, Rafael H.; Gutiérrez-Aguirre, Homero; Melo, Raul A. M.; Bittencourt, Rosane; Pasquini, Ricardo; Pagnano, Katia; Fagundes, Evandro M.; Chauffaille, Maria de Lourdes; Chiattone, Carlos S.; Martinez, Lem; Meillón, Luis A.; Gómez-Almaguer, David; Kwaan, Hau C.; Garcés-Eisele, Javier; Gallagher, Robert; Niemeyer, Charlotte M.; Schrier, Stanley L.; Tallman, Martin; Grimwade, David; Ganser, Arnold; Berliner, Nancy; Ribeiro, Raul C.; Lo-Coco, Francesco; Löwenberg, Bob; Sanz, Miguel A.
Source: Blood. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, EPIDEMIOLOGIA, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REGO, Eduardo Magalhaes et al. Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL. Blood, v. 121, n. 11, p. 1935-1943, 2013Tradução . . Disponível em: https://doi.org/10.1182/blood-2012-08-449918. Acesso em: 06 nov. 2024.
APA
Rego, E. M., Kim, H. T., Ruiz-Argüelles, G. J., Undurraga, M. S., Uriarte, M. del R., Jacomo, R. H., et al. (2013). Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL. Blood, 121( 11), 1935-1943. doi:10.1182/blood-2012-08-449918
NLM
Rego EM, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte M del R, Jacomo RH, Gutiérrez-Aguirre H, Melo RAM, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille M de L, Chiattone CS, Martinez L, Meillón LA, Gómez-Almaguer D, Kwaan HC, Garcés-Eisele J, Gallagher R, Niemeyer CM, Schrier SL, Tallman M, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA. Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL [Internet]. Blood. 2013 ; 121( 11): 1935-1943.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1182/blood-2012-08-449918
Vancouver
Rego EM, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte M del R, Jacomo RH, Gutiérrez-Aguirre H, Melo RAM, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille M de L, Chiattone CS, Martinez L, Meillón LA, Gómez-Almaguer D, Kwaan HC, Garcés-Eisele J, Gallagher R, Niemeyer CM, Schrier SL, Tallman M, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA. Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL [Internet]. Blood. 2013 ; 121( 11): 1935-1943.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1182/blood-2012-08-449918

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation